A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19

BACKGROUND: LY-CoV555, a neutralizing monoclonal antibody, has been associated with a decrease in viral load and the frequency of hospitalizations or emergency department visits among outpatients with coronavirus disease 2019 (Covid-19). Data are needed on the effect of this antibody in patients who...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781100/
https://www.ncbi.nlm.nih.gov/pubmed/33356051
http://dx.doi.org/10.1056/NEJMoa2033130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781100/
https://www.ncbi.nlm.nih.gov/pubmed/33356051
http://dx.doi.org/10.1056/NEJMoa2033130

Ejemplares similares